title: Active surveillance for prostate cancer: a review.
abstract: Active surveillance is a solution to the widely acknowledged problem of overdiagnosis and overtreatment of  clinically insignificant disease which accompanies early detection of prostate cancer using PSA and biopsy.  It is an approach to the management of favorable risk prostate cancer which uses the opportunity provided  by the long natural history of the disease to incorporate a period of initial observation into patient management. In this review article, the rationale, criteria for patient selection, method of follow up, trigger for  intervention, and results of active surveillance are reviewed.
authors: Division of Urology, Professor of Surgery, University of Toronto, Sunnybrook & Women's College Health Sciences Centre, Ontario, Canada. Laurence.klotz@sunnybrook.ca
authors: Laurence
authors: L
authors: Klotz
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis* / Q000453:epidemiology; D001707:Biopsy, Needle / Q000706:statistics & numerical data*; D005500:Follow-Up Studies; D005544:Forecasting; D006801:Humans; D008297:Male; D008403:Mass Screening; D015337:Multicenter Studies as Topic; D011159:Population Surveillance; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000453:epidemiology; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D018570:Risk Assessment; D019564:Unnecessary Procedures
chemical_list: D017430:Prostate-Specific Antigen